| Total N = 78 | Sufentanil N = 38 | Nalbuphine N = 40 | p-valuea |
---|---|---|---|---|
Gender | Â | Â | Â | 0.962 |
Male | 31 (39.7%) | 15 | 16 | Â |
Female | 47 (60.3%) | 23 | 24 | Â |
Age (year) | 53.36 ± 2.15 | 55.05 ± 3.32 | 51.75 ± 2.77 | 0.446 |
Weight (kg) | 64.63 ± 1.06 | 63.79 ± 1.64 | 65.43 ± 1.37 | 0.444 |
APACHE II | 10 (6, 17) | 13 (8, 18) | 8.5 (5, 14) | 0.072 |
Disease entity | Â | Â | Â | 0.214 |
Infectious disease | 16 (20.5%) | 9 (23.7%) | 7 (17.5%) | Â |
Trauma and accidental injury | 26 (33.3%) | 13 (34.2%) | 13 (32.5%) | Â |
Neoplasms | 10 (12.8%) | 3 (7.9%) | 7 (17.5%) | Â |
Inflammatory disease | 5 (6.4%) | 3 (7.9%) | 2 (5.0%) | Â |
Digestive systems | 7 (9.0%) | 6 (15.8%) | 1 (2.5%) | Â |
Cardiovascular system | 3 (3.8%) | 0 (0.0%) | 3 (7.5%) | Â |
Respiratory disease | 2 (2.6%) | 1 (2.6%) | 1 (2.5%) | Â |
Others | 9 (11.5%) | 3 (7.9%) | 6 (15.0%) | Â |
CPOT | 3.42 ± 0.15 | 3.42 ± 0.22 | 3.43 ± 0.21 | 0.990 |
RASS | 1.54 ± 0.09 | 1.61 ± 0.13 | 1.48 ± 0.14 | 0.493 |
SBP (mmHg) | 126.08 ± 2.31 | 128.21 ± 3.43 | 124.05 ± 3.12 | 0.371 |
DBP (mmHg) | 73.28 ± 1.40 | 71.26 ± 2.07 | 75.20 ± 1.88 | 0.162 |
HR (bpm/min) | 96.15 ± 2.53 | 99.71 ± 3.85 | 92.78 ± 3.27 | 0.172 |
SpO2 (%) | 96.92 ± 0.62 | 97.34 ± 0.64 | 96.52 ± 1.05 | 0.510 |